Chemical modification toward loss of mutagenic activity as an alternative to problems involved in risk assessment.
D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D003412:Cricetulus; D005260:Female; D006367:HeLa Cells / Q000187:drug effects; D006801:Humans; D009152:Mutagenicity Tests; D009153:Mutagens / Q000494:pharmacology*; D009154:Mutation; D010053:Ovary; D012306:Risk; D012854:Sister Chromatid Exchange
D009153:Mutagens